Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001786891 | SCV002028875 | uncertain significance | not provided | 2021-05-26 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Ambry Genetics | RCV002361053 | SCV002666638 | uncertain significance | Cardiovascular phenotype | 2022-02-09 | criteria provided, single submitter | clinical testing | The p.G2278V variant (also known as c.6833G>T), located in coding exon 18 of the TNXB gene, results from a G to T substitution at nucleotide position 6833. The glycine at codon 2278 is replaced by valine, an amino acid with dissimilar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002478019 | SCV002777823 | uncertain significance | Ehlers-Danlos syndrome due to tenascin-X deficiency; Vesicoureteral reflux 8 | 2022-04-01 | criteria provided, single submitter | clinical testing |